Skip to content
GenoLensGenoLens

SOST

Chr 17q21.31

sclerostin

Aliases:
VBCH, DAND6
MANE:
ENST00000301691.3

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Fetal anomalies

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • Osteopetrosis

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • Skeletal dysplasia

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • Osteogenesis imperfecta

Disease associations (Open Targets)

  • sclerosteosis 1

    0.70
  • craniodiaphyseal dysplasia

    0.65
  • hyperostosis corticalis generalisata

    0.64
  • osteoporosis

    0.64
  • sclerosteosis

    0.61
  • postmenopausal osteoporosis

    0.47
  • bone fracture

    0.41
  • myocardial infarction

    0.41
  • osteogenesis imperfecta

    0.41
  • bone disorder

    0.38

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Sclerostin

Negative regulator of bone growth that acts through inhibition of Wnt signaling and bone formation

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.